{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:22:58Z","timestamp":1776500578516,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ceva Innovation Center GmbH."},{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Streptoccocus\u00a0suis<\/jats:italic>\u00a0(<jats:italic>S.<\/jats:italic>\u00a0<jats:italic>suis<\/jats:italic>) is a major porcine pathogen causing meningitis, septicemia, arthritis and endocarditis. These diseases severely impair welfare of pigs. Experimental studies in pigs are important to better understand the pathogenesis and to identify protective antigens, as so far there is no vaccine available protecting against various serotypes (<jats:italic>cps<\/jats:italic>). Due to the severity of disease, application of appropriate refinement strategies in experimental <jats:italic>S.<\/jats:italic>\u00a0<jats:italic>suis<\/jats:italic> infections is essential to reduce distress imposed on the piglets without jeopardizing the scientific output. The objectives of this study were to evaluate buprenorphine treatment as a refinement measure and serum cortisol levels as a distress read out parameter in a new <jats:italic>S.<\/jats:italic>\u00a0<jats:italic>suis cps<\/jats:italic>3 infection model in pigs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Intravenous application of 2\u2009\u00d7\u200910<jats:sup>8<\/jats:sup>\u00a0CFU of <jats:italic>S.<\/jats:italic>\u00a0<jats:italic>suis cps<\/jats:italic>3 (<jats:italic>sly<\/jats:italic><jats:sup>+<\/jats:sup>, <jats:italic>mrp<\/jats:italic><jats:sup>+<\/jats:sup>) to 6-week-old piglets led to severe morbidity in approximately 50% of the animals. Main pathological findings included suppurative meningoencephalitis and arthritis as well as fibrinosuppurative endocarditis. Buprenorphine treatment (0.05\u00a0mg\/kg every 8\u00a0h) did not prevent signs of severe pain, high clinical scores, moderate to severe pathologies or high levels of serum cortisol in single severely affected piglets. Significant differences in the course of leukocytosis, induction of specific antibodies and bactericidal immunity were not recorded between groups with or w\/o buprenorphine treatment. Of note, clinically unobtrusive piglets showed serum cortisol levels at 2 and 5\u00a0days post infectionem (dpi) comparable to the levels prior to infection with <jats:italic>cps<\/jats:italic>3. Cortisol levels in serum were significantly increased in piglets euthanized due to severe disease in comparison to clinically unobtrusive pigs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Different clinical courses and pathologies are induced after intravenous challenge of piglets with 2\u2009\u00d7\u200910<jats:sup>8<\/jats:sup>\u00a0CFU of this <jats:italic>S.<\/jats:italic>\u00a0<jats:italic>suis cps<\/jats:italic>3 strain. The chosen protocol of buprenorphine application does not prevent severe distress in this infection model. Important parameters of the humoral immune response, such as the level of IgM binding to <jats:italic>S.\u00a0suis cps<\/jats:italic>3, do not appear to be affected by buprenorphine treatment. Serum cortisol is a meaningful parameter to measure distress in piglets experimentally infected with <jats:italic>S.<\/jats:italic>\u00a0<jats:italic>suis<\/jats:italic> and to evaluate refinement strategies. In this intravenous model, which includes close clinical monitoring and different humane endpoints, clinics and cortisol levels suggest convalescence in surviving piglets within 5\u00a0days following experimental infection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-022-03532-w","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T09:03:24Z","timestamp":1670835804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A new S.\u00a0suis serotype 3 infection model in pigs: lack of effect of buprenorphine treatment to reduce distress"],"prefix":"10.1186","volume":"18","author":[{"given":"Carolin","family":"Liedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almuth","family":"Einspanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Rieckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph G.","family":"Baums","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"3532_CR1","doi-asserted-by":"publisher","unstructured":"Segura M, Aragon V, Brockmeier SL, Gebhart C, Greeff A de, Kerdsin A, et al. Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis. Pathogens. 2020. https:\/\/doi.org\/10.3390\/pathogens9050374.","DOI":"10.3390\/pathogens9050374"},{"key":"3532_CR2","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1128\/AEM.67.10.4828-4833.2001","volume":"67","author":"R Brousseau","year":"2001","unstructured":"Brousseau R, Hill JE, Pr\u00e9fontaine G, Goh SH, Harel J, Hemmingsen SM. Streptococcus suis serotypes characterized by analysis of chaperonin 60 gene sequences. Appl Environ Microbiol. 2001;67:4828\u201333. https:\/\/doi.org\/10.1128\/AEM.67.10.4828-4833.2001.","journal-title":"Appl Environ Microbiol"},{"issue":"Pt 2","key":"3532_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1099\/00207713-48-2-581","volume":"48","author":"S Chatellier","year":"1998","unstructured":"Chatellier S, Harel J, Zhang Y, Gottschalk M, Higgins R, Devriese LA, Brousseau R. Phylogenetic diversity of Streptococcus suis strains of various serotypes as revealed by 16S rRNA gene sequence comparison. Int J Syst Bacteriol. 1998;48(Pt 2):581\u20139. https:\/\/doi.org\/10.1099\/00207713-48-2-581.","journal-title":"Int J Syst Bacteriol"},{"key":"3532_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1099\/jmm.0.069757-0","volume":"63","author":"A Kerdsin","year":"2014","unstructured":"Kerdsin A, Akeda Y, Hatrongjit R, Detchawna U, Sekizaki T, Hamada S, et al. Streptococcus suis serotyping by a new multiplex PCR. J Med Microbiol. 2014;63:824\u201330. https:\/\/doi.org\/10.1099\/jmm.0.069757-0.","journal-title":"J Med Microbiol"},{"key":"3532_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.vetmic.2005.12.013","volume":"115","author":"LMG Silva","year":"2006","unstructured":"Silva LMG, Baums CG, Rehm T, Wisselink HJ, Goethe R, Valentin-Weigand P. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet Microbiol. 2006;115:117\u201327. https:\/\/doi.org\/10.1016\/j.vetmic.2005.12.013.","journal-title":"Vet Microbiol"},{"key":"3532_CR6","doi-asserted-by":"publisher","first-page":"15429","DOI":"10.1038\/s41598-019-51576-0","volume":"9","author":"N Willemse","year":"2019","unstructured":"Willemse N, van der Ark KCH, Stockhofe-Zurwieden N, Smith H, Picavet DI, van Solt-Smits C, et al. Clonal expansion of a virulent Streptococcus suis serotype 9 lineage distinguishable from carriage subpopulations. Sci Rep. 2019;9:15429. https:\/\/doi.org\/10.1038\/s41598-019-51576-0.","journal-title":"Sci Rep"},{"key":"3532_CR7","first-page":"236","volume":"69","author":"F Berthelot-H\u00e9rault","year":"2005","unstructured":"Berthelot-H\u00e9rault F, Gottschalk M, Morvan H, Kobisch M. Dilemma of virulence of Streptococcus suis: Canadian isolate 89\u20131591 characterized as a virulent strain using a standardized experimental model in pigs. Can J Vet Res. 2005;69:236\u201340.","journal-title":"Can J Vet Res"},{"key":"3532_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.carres.2018.07.003","volume":"466","author":"G Goyette-Desjardins","year":"2018","unstructured":"Goyette-Desjardins G, Vinogradov E, Okura M, Takamatsu D, Gottschalk M, Segura M. Streptococcus suis serotype 3 and serotype 18 capsular polysaccharides contain di-N-acetyl-bacillosamine. Carbohyd Res. 2018;466:18\u201329. https:\/\/doi.org\/10.1016\/j.carres.2018.07.003.","journal-title":"Carbohyd Res"},{"key":"3532_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/21505594.2020.1858604","volume":"12","author":"D V\u00f6tsch","year":"2021","unstructured":"V\u00f6tsch D, Willenborg M, Baumg\u00e4rtner W, Rohde M, Valentin-Weigand P. Bordetella bronchiseptica promotes adherence, colonization, and cytotoxicity of Streptococcus suis in a porcine precision-cut lung slice model. Virulence. 2021;12:84\u201395. https:\/\/doi.org\/10.1080\/21505594.2020.1858604.","journal-title":"Virulence"},{"key":"3532_CR10","doi-asserted-by":"publisher","unstructured":"Hohnstein FS, Meurer M, Buhr N de, K\u00f6ckritz-Blickwede M von, Baums CG, Alber G, Sch\u00fctze N. Analysis of Porcine Pro- and Anti-Inflammatory Cytokine Induction by S. suis In Vivo and In Vitro. Pathogens. 2020. https:\/\/doi.org\/10.3390\/pathogens9010040.","DOI":"10.3390\/pathogens9010040"},{"key":"3532_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00598-19","author":"V Rungelrath","year":"2020","unstructured":"Rungelrath V, \u00d6hlmann S, Alber G, Schr\u00f6dl W, von K\u00f6ckritz-Blickwede M, de Buhr N, et al. Survival of streptococcus suis in porcine blood is limited by the antibody- and complement-dependent oxidative burst response of granulocytes. Infect Immun. 2020. https:\/\/doi.org\/10.1128\/IAI.00598-19.","journal-title":"Infect Immun"},{"key":"3532_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens6010013","author":"L Martelet","year":"2017","unstructured":"Martelet L, Lacouture S, Goyette-Desjardins G, Beauchamp G, Surprenant C, Gottschalk M, Segura M. Porcine dendritic cells as an in vitro model to assess the immunological behaviour of streptococcus suis subunit vaccine formulations and the polarizing effect of adjuvants. Pathogens. 2017. https:\/\/doi.org\/10.3390\/pathogens6010013.","journal-title":"Pathogens"},{"key":"3532_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1574-695X.2006.00067.x","volume":"47","author":"M Segura","year":"2006","unstructured":"Segura M, Vanier G, Al-Numani D, Lacouture S, Olivier M, Gottschalk M. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol Med Microbiol. 2006;47:92\u2013106. https:\/\/doi.org\/10.1111\/j.1574-695X.2006.00067.x.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3532_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13567-021-00981-3","volume":"52","author":"C Wei\u00dfe","year":"2021","unstructured":"Wei\u00dfe C, Dittmar D, Jak\u00f3bczak B, Florian V, Sch\u00fctze N, Alber G, et al. Immunogenicity and protective efficacy of a Streptococcus suis vaccine composed of six conserved immunogens. Vet Res. 2021;52:112. https:\/\/doi.org\/10.1186\/s13567-021-00981-3.","journal-title":"Vet Res"},{"key":"3532_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cimid.2016.06.001","volume":"47","author":"L G\u00f3mez-Gasc\u00f3n","year":"2016","unstructured":"G\u00f3mez-Gasc\u00f3n L, Cardoso-Toset F, Tarradas C, G\u00f3mez-Laguna J, Maldonado A, Nielsen J, et al. Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs. Comp Immunol Microbiol Infect Dis. 2016;47:52\u20139. https:\/\/doi.org\/10.1016\/j.cimid.2016.06.001.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"3532_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12917-016-0937-8","volume":"13","author":"K-J Hsueh","year":"2017","unstructured":"Hsueh K-J, Cheng L-T, Lee J-W, Chung Y-C, Chung W-B, Chu C-Y. Immunization with Streptococcus suis bacterin plus recombinant Sao protein in sows conveys passive immunity to their piglets. BMC Vet Res. 2017;13:15. https:\/\/doi.org\/10.1186\/s12917-016-0937-8.","journal-title":"BMC Vet Res"},{"key":"3532_CR17","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1038\/emi.2014.45","volume":"3","author":"G Goyette-Desjardins","year":"2014","unstructured":"Goyette-Desjardins G, Auger J-P, Xu J, Segura M, Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect. 2014;3:e45. https:\/\/doi.org\/10.1038\/emi.2014.45.","journal-title":"Emerg Microbes Infect"},{"key":"3532_CR18","first-page":"841","volume-title":"Disease of swine","author":"GM Streptococcosis","year":"2012","unstructured":"Streptococcosis GM. In: Zimmerman J, Karriker L, Ramirez A, Schwartz K, Stevenson G, editors. Disease of swine. 10th ed. Hoboken: John Wiley & Sons; 2012. p. 841\u201355.","edition":"10"},{"key":"3532_CR19","unstructured":"Margarete Arras, Kristianna Becker, Alessandra Bergadano et al. Pain management for laboratory animals. July 2020. https:\/\/www.gv-solas.de\/wp-content\/uploads\/2021\/08\/2021-04_Pain_Management_for_laboratory_animals.pdf. Accessed 11 June 2022."},{"key":"3532_CR20","doi-asserted-by":"publisher","first-page":"e0260356","DOI":"10.1371\/journal.pone.0260356","volume":"17","author":"MS Berke","year":"2022","unstructured":"Berke MS, Fensholdt LKD, Hestehave S, Kalliokoski O, Abelson KSP. Effects of buprenorphine on model development in an adjuvant-induced monoarthritis rat model. PLoS One. 2022;17:e0260356. https:\/\/doi.org\/10.1371\/journal.pone.0260356.","journal-title":"PLoS One"},{"key":"3532_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/laban.152","volume":"41","author":"M Guarnieri","year":"2012","unstructured":"Guarnieri M, Brayton C, DeTolla L, Forbes-McBean N, Sarabia-Estrada R, Zadnik P. Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats. Lab Anim (NY). 2012;41:337\u201343. https:\/\/doi.org\/10.1038\/laban.152.","journal-title":"Lab Anim (NY)"},{"key":"3532_CR22","first-page":"469","volume":"67","author":"NC Peterson","year":"2017","unstructured":"Peterson NC, Nunamaker EA, Turner PV. To treat or not to treat: the effects of pain on experimental parameters. Comp Med. 2017;67:469\u201382.","journal-title":"Comp Med"},{"key":"3532_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/bja\/aev301","volume":"116","author":"AG Bradbury","year":"2016","unstructured":"Bradbury AG, Eddleston M, Clutton RE. Pain management in pigs undergoing experimental surgery; a literature review (2012\u20134). Br J Anaesth. 2016;116:37\u201345. https:\/\/doi.org\/10.1093\/bja\/aev301.","journal-title":"Br J Anaesth"},{"issue":"Suppl 1","key":"3532_CR24","doi-asserted-by":"publisher","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","volume":"20","author":"P Sacerdote","year":"2006","unstructured":"Sacerdote P. Opioids and the immune system. Palliat Med. 2006;20(Suppl 1):s9-15.","journal-title":"Palliat Med"},{"key":"3532_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/s0165-5728(97)00219-1","volume":"83","author":"TK Eisenstein","year":"1998","unstructured":"Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol. 1998;83:36\u201344. https:\/\/doi.org\/10.1016\/s0165-5728(97)00219-1.","journal-title":"J Neuroimmunol"},{"key":"3532_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12917-018-1643-5","volume":"14","author":"AV Viscardi","year":"2018","unstructured":"Viscardi AV, Turner PV. Efficacy of buprenorphine for management of surgical castration pain in piglets. BMC Vet Res. 2018;14:318. https:\/\/doi.org\/10.1186\/s12917-018-1643-5.","journal-title":"BMC Vet Res"},{"key":"3532_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tvjl.2015.10.016","volume":"206","author":"E Meijer","year":"2015","unstructured":"Meijer E, van Nes A, Back W, van der Staay FJ. Clinical effects of buprenorphine on open field behaviour and gait symmetry in healthy and lame weaned piglets. Vet J. 2015;206:298\u2013303. https:\/\/doi.org\/10.1016\/j.tvjl.2015.10.016.","journal-title":"Vet J"},{"key":"3532_CR28","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1128\/IAI.00359-06","volume":"74","author":"CG Baums","year":"2006","unstructured":"Baums CG, Kaim U, Fulde M, Ramachandran G, Goethe R, Valentin-Weigand P. Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect Immun. 2006;74:6154\u201362. https:\/\/doi.org\/10.1128\/IAI.00359-06.","journal-title":"Infect Immun"},{"key":"3532_CR29","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.jvacx.2019.100046","volume":"3","author":"K Rieckmann","year":"2019","unstructured":"Rieckmann K, Seydel A, Klose K, Alber G, Baums CG, Sch\u00fctze N. Vaccination with the immunoglobulin M-degrading enzyme of Streptococcus suis, Ide Ssuis, leads to protection against a highly virulent serotype 9 strain. Vaccine X. 2019;3:100046. https:\/\/doi.org\/10.1016\/j.jvacx.2019.100046.","journal-title":"Vaccine X"},{"key":"3532_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1128\/CVI.00371-08","volume":"16","author":"CG Baums","year":"2009","unstructured":"Baums CG, Kock C, Beineke A, Bennecke K, Goethe R, Schr\u00f6der C, et al. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9. Clin Vaccine Immunol. 2009;16:200\u20138. https:\/\/doi.org\/10.1128\/CVI.00371-08.","journal-title":"Clin Vaccine Immunol"},{"key":"3532_CR31","doi-asserted-by":"publisher","unstructured":"Meurer M, \u00d6hlmann S, Bonilla MC, Valentin-Weigand P, Beineke A, Hennig-Pauka I, et al. Role of Bacterial and Host DNases on Host-Pathogen Interaction during Streptococcus suis Meningitis. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21155289.","DOI":"10.3390\/ijms21155289"},{"key":"3532_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s10753-017-0692-4","volume":"41","author":"Y Sun","year":"2018","unstructured":"Sun Y, Liu H, Du R, Li S, Qu G, Zhu R, et al. Characteristic comparison of meningitis and non-meningitis of streptococcus suis in an experimentally infected porcine model. Inflammation. 2018;41:368\u201377. https:\/\/doi.org\/10.1007\/s10753-017-0692-4.","journal-title":"Inflammation"},{"key":"3532_CR33","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.vaccine.2015.03.047","volume":"33","author":"J Seele","year":"2015","unstructured":"Seele J, Hillermann L-M, Beineke A, Seitz M, von Pawel-Rammingen U, Valentin-Weigand P, Baums CG. The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2. Vaccine. 2015;33:2207\u201312. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.047.","journal-title":"Vaccine"},{"key":"3532_CR34","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1016\/j.vaccine.2011.07.010","volume":"29","author":"J Li","year":"2011","unstructured":"Li J, Xia J, Tan C, Zhou Y, Wang Y, Zheng C, et al. Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2. Vaccine. 2011;29:6514\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.010.","journal-title":"Vaccine"},{"key":"3532_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fvets.2016.00108","volume":"3","author":"SH Ison","year":"2016","unstructured":"Ison SH, Clutton RE, Di Giminiani P, Rutherford KMD. A review of pain assessment in pigs. Front Vet Sci. 2016;3:108. https:\/\/doi.org\/10.3389\/fvets.2016.00108.","journal-title":"Front Vet Sci"},{"key":"3532_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/iai.60.2.550-556.1992","volume":"60","author":"U Vecht","year":"1992","unstructured":"Vecht U, Wisselink HJ, van Dijk JE, Smith HE. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect Immun. 1992;60:550\u20136. https:\/\/doi.org\/10.1128\/iai.60.2.550-556.1992.","journal-title":"Infect Immun"},{"key":"3532_CR37","first-page":"196","volume":"65","author":"F Berthelot-H\u00e9rault","year":"2001","unstructured":"Berthelot-H\u00e9rault F, Cariolet R, Labb\u00e9 A, Gottschalk M, Cardinal JY, Kobisch M. Experimental infection of specific pathogen free piglets with French strains of Streptococcus suis capsular type 2. Can J Vet Res. 2001;65:196\u2013200.","journal-title":"Can J Vet Res"},{"key":"3532_CR38","doi-asserted-by":"publisher","first-page":"e005093","DOI":"10.1099\/jmmcr.0.005093","volume":"4","author":"K Rieckmann","year":"2017","unstructured":"Rieckmann K, M\u00fcller K, Moter A, Baums CG, Seydel A. Streptococcus suis serotype 9 endocarditis and subsequent severe meningitis in a growing pig despite specific bactericidal humoral immunity. JMM Case Rep. 2017;4:e005093. https:\/\/doi.org\/10.1099\/jmmcr.0.005093.","journal-title":"JMM Case Rep"},{"key":"3532_CR39","volume-title":"Disease of swine","year":"2012","unstructured":"Zimmerman J, Karriker L, Ramirez A, Schwartz K, Stevenson G, editors. Disease of swine. 10th ed. Hoboken: John Wiley & Sons; 2012.","edition":"10"},{"key":"3532_CR40","first-page":"185","volume":"50","author":"JT Tubbs","year":"2011","unstructured":"Tubbs JT, Kissling GE, Travlos GS, Goulding DR, Clark JA, King-Herbert AP, Blankenship-Paris TL. Effects of buprenorphine, meloxicam, and flunixin meglumine as postoperative analgesia in mice. J Am Assoc Lab Anim Sci. 2011;50:185\u201391.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"3532_CR41","first-page":"17","volume":"40","author":"NA Rodriguez","year":"2001","unstructured":"Rodriguez NA, Cooper DM, Risdahl JM. Antinociceptive activity of and clinical experience with buprenorphine in swine. Contemp Top Lab Anim Sci. 2001;40:17\u201320.","journal-title":"Contemp Top Lab Anim Sci"},{"key":"3532_CR42","doi-asserted-by":"publisher","unstructured":"Goyette-Desjardins G, Auger J-P, Dolbec D, Vinogradov E, Okura M, Takamatsu D, et al. Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Streptococcus suis Serotypes 3, 7, 8, and 9: the Serotype 3 Polysaccharide Induces an Opsonizing IgG Response. Infect Immun. 2020. https:\/\/doi.org\/10.1128\/IAI.00377-20.","DOI":"10.1128\/IAI.00377-20"},{"key":"3532_CR43","first-page":"224","volume":"51","author":"CE Hanson","year":"2001","unstructured":"Hanson CE, Ruble GR, Essiet I, Hartman AB. Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test). Comp Med. 2001;51:224\u20139.","journal-title":"Comp Med"},{"key":"3532_CR44","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1017\/S1751731112002406","volume":"7","author":"A Prunier","year":"2013","unstructured":"Prunier A, Mounier L, Le Neindre P, Leterrier C, Morm\u00e8de P, Paulmier V, et al. Identifying and monitoring pain in farm animals: a review. Animal. 2013;7:998\u20131010. https:\/\/doi.org\/10.1017\/S1751731112002406.","journal-title":"Animal"},{"key":"3532_CR45","doi-asserted-by":"publisher","first-page":"109183","DOI":"10.1016\/j.vetmic.2021.109183","volume":"260","author":"L Mayer","year":"2021","unstructured":"Mayer L, Bornemann N, Lehnert S, de Greeff A, Strutzberg-Minder K, Rieckmann K, Baums CG. Survival patterns of Streptococcus suis serotypes 1 and 14 in porcine blood indicate cross-reactive bactericidal antibodies in naturally infected pigs. Vet Microbiol. 2021;260:109183. https:\/\/doi.org\/10.1016\/j.vetmic.2021.109183.","journal-title":"Vet Microbiol"},{"key":"3532_CR46","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1128\/IAI.67.4.1750-1756.1999","volume":"67","author":"HE Smith","year":"1999","unstructured":"Smith HE, Damman M, van der Velde J, Wagenaar F, Wisselink HJ, Stockhofe-Zurwieden N, Smits MA. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun. 1999;67:1750\u20136. https:\/\/doi.org\/10.1128\/IAI.67.4.1750-1756.1999.","journal-title":"Infect Immun"},{"key":"3532_CR47","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1099\/jmm.0.048587-0","volume":"61","author":"A Kerdsin","year":"2012","unstructured":"Kerdsin A, Dejsirilert S, Akeda Y, Sekizaki T, Hamada S, Gottschalk M, Oishi K. Fifteen Streptococcus suis serotypes identified by multiplex PCR. J Med Microbiol. 2012;61:1669\u201372. https:\/\/doi.org\/10.1099\/jmm.0.048587-0.","journal-title":"J Med Microbiol"},{"key":"3532_CR48","doi-asserted-by":"publisher","unstructured":"Athey TBT, Teatero S, Lacouture S, Takamatsu D, Gottschalk M, Fittipaldi N. Determining Streptococcus suis serotype from short-read whole-genome sequencing data. BMC Microbiol. 2016. https:\/\/doi.org\/10.1186\/s12866-016-0782-8.","DOI":"10.1186\/s12866-016-0782-8"},{"key":"3532_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.vetimm.2012.03.012","volume":"146","author":"N B\u00fcttner","year":"2012","unstructured":"B\u00fcttner N, Beineke A, de Buhr N, Lilienthal S, Merkel J, Waldmann K-H, et al. Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy. Vet Immunol Immunopathol. 2012;146:191\u2013200. https:\/\/doi.org\/10.1016\/j.vetimm.2012.03.012.","journal-title":"Vet Immunol Immunopathol"},{"key":"3532_CR50","doi-asserted-by":"publisher","first-page":"822369","DOI":"10.3389\/fmicb.2022.822369","volume":"13","author":"S \u00d6hlmann","year":"2022","unstructured":"\u00d6hlmann S, Krieger A-K, Gisch N, Meurer M, de Buhr N, von K\u00f6ckritz-Blickwede M, et al. d-Alanylation of Lipoteichoic Acids in Streptococcus suis Reduces Association With Leukocytes in Porcine Blood. Front Microbiol. 2022;13:822369. https:\/\/doi.org\/10.3389\/fmicb.2022.822369.","journal-title":"Front Microbiol"},{"key":"3532_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21836\/PEM20170307","volume":"33","author":"MI Adam","year":"2017","unstructured":"Adam MI, K\u00f6ller G, Arnold C, Schusser GF. Effects of using Flunixin Meglumine, Metamizole, and Phenylbutazone on equine kidney functions, urinary mucus, and secretory Immunoglobulin A (IgA) concentrations. PHK. 2017;33:263\u201370. https:\/\/doi.org\/10.21836\/PEM20170307.","journal-title":"PHK"},{"key":"3532_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1017\/S1751731107001279","volume":"2","author":"E Hillmann","year":"2008","unstructured":"Hillmann E, Schrader L, Mayer C, Gygax L. Effects of weight, temperature and behaviour on the circadian rhythm of salivary cortisol in growing pigs. Animal. 2008;2:405\u20139. https:\/\/doi.org\/10.1017\/S1751731107001279.","journal-title":"Animal"},{"key":"3532_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/s0031-9384(97)00177-7","volume":"62","author":"M Ruis","year":"1997","unstructured":"Ruis M. The circadian rhythm of salivary cortisol in growing pigs: effects of age, gender, and stress. Physiol Behav. 1997;62:623\u201330. https:\/\/doi.org\/10.1016\/s0031-9384(97)00177-7.","journal-title":"Physiol Behav"},{"key":"3532_CR54","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.2527\/jas.2016-0365","volume":"94","author":"G Da\u015f","year":"2016","unstructured":"Da\u015f G, Vernunft A, G\u00f6rs S, Kanitz E, Weitzel JM, Br\u00fcssow K-P, Metges CC. Effects of general anesthesia with ketamine in combination with the neuroleptic sedatives xylazine or azaperone on plasma metabolites and hormones in pigs. J Anim Sci. 2016;94:3229\u201339. https:\/\/doi.org\/10.2527\/jas.2016-0365.","journal-title":"J Anim Sci"},{"key":"3532_CR55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.rvsc.2010.06.026","volume":"90","author":"J Gottschalk","year":"2011","unstructured":"Gottschalk J, Einspanier A, Ungemach FR, Abraham G. Influence of topical dexamethasone applications on insulin, glucose, thyroid hormone and cortisol levels in dogs. Res Vet Sci. 2011;90:491\u20137. https:\/\/doi.org\/10.1016\/j.rvsc.2010.06.026.","journal-title":"Res Vet Sci"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-022-03532-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T22:10:28Z","timestamp":1671142228000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-022-03532-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3532"],"URL":"https:\/\/doi.org\/10.1186\/s12917-022-03532-w","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"19 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments or samplings were conducted by veterinarians and in accordance with the guidelines outlined in the EU\u00a0Directive\u00a02010\/63\/EU, the European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes and the German Animal Protection Law (Tierschutzgesetz). The animal experiment was approved by the Landesdirektion Sachsen (permit no. TVV58\/20) as regulated by \u00a715 of the German Animal Protection Law. The Animal Protection Committee of the Landesdirektion Sachsen (Ethics Committee) is involved in the process of approval of the animal experiment by the Landesdirektion Sachsen. Collection of blood from non-infected piglets for scientific purposes is registered under the permit number A09\/19. All methods are in accordance with the ARRIVE guidelines for the reporting of animal experiments. All reported methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ceva Innovation Center GmbH is a company developing veterinary vaccines. Research of CGB and parts of this study were funded by Ceva Innovation Center GmbH.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}